Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Breyanzi
Pharma
BMS' Breyanzi bags FDA nod to treat follicular lymphoma
The FDA broadened the use of BMS' CAR-T therapy Breyanzi to another type of blood cancer, where it'll again compete with Gilead and Novartis drugs.
Angus Liu
May 16, 2024 10:56am
BMS signs $380M deal with cell therapy manufacturer Cellares
Apr 22, 2024 11:10am
Bristol Myers bags FDA nod to bring CAR-T to CLL
Mar 15, 2024 9:46am
BMS CEO outlines transition strategy featuring 11 brands, BD
Feb 2, 2024 11:30am
FDA wants classwide boxed warning on existing CAR-Ts
Jan 23, 2024 3:27am
Cell therapy bigwigs endorse CAR-T in Nature Medicine article
Jan 9, 2024 5:00am